IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Biocon and Mylan to Collaborate in Generic Biologics

7:45 AM MDT | July 13, 2009 | Deepti Ramesh

Mylan (Canonsburg, PA) says it has signed an agreement with biotechnology firm Biocon (Bangalore, India) for an exclusive collaboration for the development, manufacturing, and commercialization of multiple, high-value generic biologic compounds for the global market. Mazumdar-Shaw: To lower healthcare costs. The generic pharmaceutical industry, which is based almost entirely on chemically synthesized drugs, is poised for change, Biocon says. Governments worldwide are trying to facilitate the entry of generic biotech or protein derived drugs, in an effort to lower...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa